Literature DB >> 33390002

Inhibition of the Clostridioides difficile Class D β-Lactamase CDD-1 by Avibactam.

Nichole K Stewart1, Marta Toth1, Anastasiya Stasyuk2, Mijoon Lee1, Clyde A Smith2,3, Sergei B Vakulenko1.   

Abstract

Avibactam is a potent diazobicyclooctane inhibitor of class A and C β-lactamases. The inhibitor also exhibits variable activity against some class D enzymes from Gram-negative bacteria; however, its interaction with recently discovered class D β-lactamases from Gram-positive bacteria has not been studied. Here, we describe microbiological, kinetic, and mass spectrometry studies of the interaction of avibactam with CDD-1, a class D β-lactamase from the clinically important pathogen Clostridioides difficile, and show that avibactam is a potent irreversible mechanism-based inhibitor of the enzyme. X-ray crystallographic studies at three time-points demonstrate the rapid formation of a stable CDD-1-avibactam acyl-enzyme complex and highlight differences in the anchoring of the inhibitor by class D enzymes from Gram-positive and Gram-negative bacteria.

Entities:  

Keywords:  Clostridioides difficile; avibactam; crystal structure; inhibition; kinetics; β-lactamase

Mesh:

Substances:

Year:  2021        PMID: 33390002      PMCID: PMC8826747          DOI: 10.1021/acsinfecdis.0c00714

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  57 in total

Review 1.  Clostridium difficile infection.

Authors:  Daniel A Leffler; J Thomas Lamont
Journal:  N Engl J Med       Date:  2015-04-16       Impact factor: 91.245

2.  Structural basis for progression toward the carbapenemase activity in the GES family of β-lactamases.

Authors:  Clyde A Smith; Hilary Frase; Marta Toth; Malika Kumarasiri; Kwame Wiafe; Jared Munoz; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Am Chem Soc       Date:  2012-11-16       Impact factor: 15.419

Review 3.  Recent advances in the development of β-lactamase inhibitors.

Authors:  Shivakumar S Jalde; Hyun Kyung Choi
Journal:  J Microbiol       Date:  2020-07-27       Impact factor: 3.422

4.  An antibiotic-resistance enzyme from a deep-sea bacterium.

Authors:  Marta Toth; Clyde Smith; Hilary Frase; Shahriar Mobashery; Sergei Vakulenko
Journal:  J Am Chem Soc       Date:  2010-01-20       Impact factor: 15.419

5.  Crystal structure of carbapenemase OXA-58 from Acinetobacter baumannii.

Authors:  Clyde A Smith; Nuno Tiago Antunes; Marta Toth; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

6.  Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus.

Authors:  J Andrew N Alexander; Mariia Radaeva; Dustin T King; Henry F Chambers; Artem Cherkasov; Som S Chatterjee; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

Review 7.  New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.

Authors:  Sarah M Drawz; Krisztina M Papp-Wallace; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

Review 8.  Burden of Clostridium difficile on the healthcare system.

Authors:  Erik R Dubberke; Margaret A Olsen
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

9.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases.

Authors:  Nichole K Stewart; Clyde A Smith; Hilary Frase; D J Black; Sergei B Vakulenko
Journal:  Biochemistry       Date:  2014-12-22       Impact factor: 3.162

View more
  1 in total

1.  In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D β-lactamases.

Authors:  Nichole K Stewart; Marta Toth; Anastasiya Stasyuk; Sergei B Vakulenko; Clyde A Smith
Journal:  ACS Infect Dis       Date:  2021-04-28       Impact factor: 5.578

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.